Peng Fan
North Hollywood, CANPI 1104801463
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $192,704 of the $231,581 with a category attached, or 83.2%. 11 manufacturers reported payments, led by Amgen at 49.2% of the total. Reporting peaked in 2019 at $184,396 and has fallen 96.1% since, to $7,277 in 2024.
Across 375 payments — averaging $617.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$114K
- Novartis$36K
- Sanofi$22K
- Pfizer$21K
- AbbVie$18K
- Radius Health, Inc.$16K
- plus $5K from 5 others
What the payments were for
- Speaking & faculty fees$192,70483%
- Travel & lodging$30,38313%
- Food & beverage$8,3954%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 171 | $113,901 |
| Novartis | 71 | $36,027 |
| Sanofi | 29 | $22,329 |
| Pfizer | 30 | $20,865 |
| AbbVie | 33 | $17,572 |
| Radius Health, Inc. | 18 | $15,824 |
| Regeneron Healthcare Solutions, Inc. | 15 | $4,812 |
| Sanofi-aventis U.S. LLC | 2 | $137 |
| GSK | 4 | $75 |
| Johnson & Johnson | 1 | $19 |
| Boston Scientific | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.